Xbrane Biopharma changes the date for Interim and Year-end Report

Corporate Information


Financial calendar



Xbrane Biopharma AB (publ) (”Xbrane” or ”the Company”) (Nasdaq Stockholm: XBRANE) announces today change of date for the Interim Report for the fourth quarter 2021 as well as the 2021 Year-end Report, to February 24, 2022, from previously communicated February 16, 2022.

The Company hereby also invites to a phone conference for investors, analysts, and media on Thursday 24 February 2022 at 10:00 am CET when the Interim report will be presented.